Mehta RS - Search Results

1

Safety, tolerability, pharmacodynamics and pharmacokinetics of umeclidinium and vilanterol alone and in combination: a randomized crossover trial.

Kelleher DL, Mehta RS, Jean-Francois BM, Preece AF, Blowers J, Crater GD, Thomas P. Kelleher DL, et al. Among authors: mehta rs. PLoS One. 2012;7(12):e50716. doi: 10.1371/journal.pone.0050716. Epub 2012 Dec 17. PLoS One. 2012. PMID: 23284643 Free PMC article. Clinical Trial.

2

Efficacy and safety of the long-acting muscarinic antagonist GSK233705 delivered once daily in patients with COPD.

Bateman E, Feldman G, Kilbride S, Brooks J, Mehta R, Harris S, Maden C, Crater G. Bateman E, et al. Clin Respir J. 2012 Oct;6(4):248-57. doi: 10.1111/j.1752-699X.2011.00278.x. Epub 2012 Feb 13. Clin Respir J. 2012. PMID: 22329914 Clinical Trial.

3

A randomized, double-blind dose-ranging study of the novel LAMA GSK573719 in patients with COPD.

Donohue JF, Anzueto A, Brooks J, Mehta R, Kalberg C, Crater G. Donohue JF, et al. Respir Med. 2012 Jul;106(7):970-9. doi: 10.1016/j.rmed.2012.03.012. Epub 2012 Apr 10. Respir Med. 2012. PMID: 22498110 Free article. Clinical Trial.

4

28-Day safety and tolerability of umeclidinium in combination with vilanterol in COPD: a randomized placebo-controlled trial.

Feldman G, Walker RR, Brooks J, Mehta R, Crater G. Feldman G, et al. Pulm Pharmacol Ther. 2012 Dec;25(6):465-71. doi: 10.1016/j.pupt.2012.08.007. Epub 2012 Aug 31. Pulm Pharmacol Ther. 2012. PMID: 22955035 Clinical Trial.

5

Bronchodilation of umeclidinium, a new long-acting muscarinic antagonist, in COPD patients.

Decramer M, Maltais F, Feldman G, Brooks J, Harris S, Mehta R, Crater G. Decramer M, et al. Respir Physiol Neurobiol. 2013 Jan 15;185(2):393-9. doi: 10.1016/j.resp.2012.08.022. Epub 2012 Sep 28. Respir Physiol Neurobiol. 2013. PMID: 23026438 Clinical Trial.

6

Initial assessment of single and repeat doses of inhaled umeclidinium in patients with chronic obstructive pulmonary disease: two randomised studies.

Tal-Singer R, Cahn A, Mehta R, Preece A, Crater G, Kelleher D, Pouliquen IJ. Tal-Singer R, et al. Eur J Pharmacol. 2013 Feb 15;701(1-3):40-8. doi: 10.1016/j.ejphar.2012.12.019. Epub 2012 Dec 28. Eur J Pharmacol. 2013. PMID: 23276660 Clinical Trial.

7

Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study.

Mehta R, Kelleher D, Preece A, Hughes S, Crater G. Mehta R, et al. Int J Chron Obstruct Pulmon Dis. 2013;8:159-67. doi: 10.2147/COPD.S40859. Epub 2013 Mar 27. Int J Chron Obstruct Pulmon Dis. 2013. PMID: 23569370 Free PMC article. Clinical Trial.

8

Safety, tolerability, pharmacokinetics and pharmacodynamics of single and repeat inhaled doses of umeclidinium in healthy subjects: two randomized studies.

Cahn A, Tal-Singer R, Pouliquen IJ, Mehta R, Preece A, Hardes K, Crater G, Deans A. Cahn A, et al. Clin Drug Investig. 2013 Jul;33(7):477-88. doi: 10.1007/s40261-013-0088-7. Clin Drug Investig. 2013. PMID: 23784369 Clinical Trial.

9

Safety, tolerability and pharmacokinetics and pharmacodynamics of inhaled once-daily umeclidinium in healthy adults deficient in CYP2D6 activity: a double-blind, randomized clinical trial.

Cahn A, Mehta R, Preece A, Blowers J, Donald A. Cahn A, et al. Clin Drug Investig. 2013 Sep;33(9):653-64. doi: 10.1007/s40261-013-0109-6. Clin Drug Investig. 2013. PMID: 23881566 Clinical Trial.

10

Umeclidinium in patients with COPD: a randomised, placebo-controlled study.

Trivedi R, Richard N, Mehta R, Church A. Trivedi R, et al. Eur Respir J. 2014 Jan;43(1):72-81. doi: 10.1183/09031936.00033213. Epub 2013 Aug 15. Eur Respir J. 2014. PMID: 23949963 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters